Vivos Therapeutics (VVOS) Cost of Revenue (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Cost of Revenue of $2.1 million for Q1 2026, up 38.16% year-over-year from $1.5 million in Q1 2025, and up 149.04% quarter-over-quarter from $836000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Cost of Revenue (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Cost of Revenue for 7 consecutive years, with $2.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cost of Revenue rose 38.16% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $7.5 million (up 23.8% YoY), while the FY2025 annual figure was $6.9 million, up 14.79% from the prior year.
- Cost of Revenue rose to $2.1 million in Q1 2026 per VVOS's latest filing, from $836000.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $2.8 million in Q3 2025 and bottomed at $836000.0 in Q4 2025.
- Historically, Cost of Revenue has averaged $1.6 million across 5 years, with a median of $1.5 million in 2024.
- On a YoY basis, Cost of Revenue climbed as much as 86.5% in 2025 and fell as far as 47.78% in 2025.
- Vivos Therapeutics' Cost of Revenue stood at $1.6 million in 2022, then slipped by 25.99% to $1.2 million in 2023, then surged by 38.14% to $1.6 million in 2024, then sank by 47.78% to $836000.0 in 2025, then jumped by 149.04% to $2.1 million in 2026.
- Business Quant data shows VVOS's Cost of Revenue at $2.1 million in Q1 2026, $836000.0 in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Vivos Therapeutics | 4.81 Mn | 3.01 Mn | 2.95 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.08 Mn |
| Mar 31, 2026 | 2.08 Mn |
| Dec 31, 2025 | 836,000.00 |
| Dec 31, 2025 | 836,000.00 |
| Sep 30, 2025 | 2.85 Mn |
| Sep 30, 2025 | 2.85 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.51 Mn |
| Mar 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Dec 31, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.53 Mn |
| Sep 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.16 Mn |
| Dec 31, 2023 | 1.16 Mn |